157 results
Keyword Albumina Grifols Remove keyword
-
List item
Human medicine European public assessment report (EPAR): Extavia
interferon beta-1b, Multiple Sclerosis
Date of authorisation: 20/05/2008, Revision: 25, Authorised, Last updated: 16/01/2023 -
List item
Human medicine European public assessment report (EPAR): Elzonris
tagraxofusp, Lymphoma
Date of authorisation: 07/01/2021,
, 
, 
, Revision: 6, Authorised, Last updated: 15/03/2023
-
List item
National expert: Leire Solis Garate, European Medicines Agency (updated)
- Declaration of interests - 43.32 KB | PDF
- Curriculum Vitae - 36.5 KB | PDF
company Subject Matter Grifols Project and activity funding Octapharma … -
List item
National expert: Jose Drabwell, European Medicines Agency (updated)
- Declaration of interests - 41.39 KB | PDF
- Curriculum Vitae - 24.12 KB | PDF
funding INVITAE Project funding GRIFOLS Project and activity funding PERKER … -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 11 to 14 September 2017
CHMP, Last updated: 15/09/2017Marketing-authorisation applicant Instituto Grifols, S.A. Therapeutic A medical … -
List item
Human medicine European public assessment report (EPAR): Betaferon
interferon beta-1b, Multiple Sclerosis
Date of authorisation: 30/11/1995, Revision: 35, Authorised, Last updated: 12/01/2023 -
List item
Human medicine European public assessment report (EPAR): Kiovig
human normal immunoglobulin (IVIg), Purpura, Thrombocytopenic, Idiopathic; Bone Marrow Transplantation; Immunologic Deficiency Syndromes; Guillain-Barre Syndrome; Mucocutaneous Lymph Node Syndrome
Date of authorisation: 18/01/2006, Revision: 26, Authorised, Last updated: 27/06/2022 -
List item
Human medicine European public assessment report (EPAR): IntronA
interferon alfa-2b, Carcinoid Tumor; Leukemia, Hairy Cell; Lymphoma, Follicular; Hepatitis B, Chronic; Hepatitis C, Chronic; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Melanoma; Multiple Myeloma
Date of authorisation: 09/03/2000, Revision: 34, Withdrawn, Last updated: 15/12/2022 -
List item
Human medicine European public assessment report (EPAR): Abraxane
paclitaxel, Breast Neoplasms; Pancreatic Neoplasms; Carcinoma, Non-Small-Cell Lung
Date of authorisation: 11/01/2008, Revision: 29, Authorised, Last updated: 13/05/2022 -
List item
National expert: Francesco Rodeghiero, European Medicines Agency (updated)
- Declaration of interests - 44.02 KB | PDF
- Curriculum Vitae - 123.49 KB | PDF
gaps. Past 03-12- 2020 18-01- 2021 Grifols Individual product related Fostamatinib … -
List item
National expert: Patricia Felgueiras Seabra Durao, European Medicines Agency (updated)
- Declaration of interests - 43.11 KB | PDF
- Curriculum Vitae - 30.36 KB | PDF
AB; Chiesi; CSL BEHRING; GRIFOLS S.A.; Healx Ltd.; Horizon … -
List item
National expert: Stefan Teipel, European Medicines Agency (updated)
- Declaration of interests - 48.01 KB | PDF
- Curriculum Vitae - 27.58 KB | PDF
Board Past 01-04- 2021 01-04- 2021 Grifols Deutschland GmbH Cross … -
List item
National expert: Francois Houyez, European Medicines Agency (updated)
- Declaration of interests - 44.66 KB | PDF
- Curriculum Vitae - 35.57 KB | PDF
company Subject Matter Illumina, GRIFOLS S.A. Eurordis Round Table … -
List item
Human medicine European public assessment report (EPAR): Hizentra
human normal immunoglobulin (SCIg), Immunologic Deficiency Syndromes
Date of authorisation: 14/04/2011, Revision: 21, Authorised, Last updated: 13/01/2022 -
List item
Human medicine European public assessment report (EPAR): Viraferon
interferon alfa-2b, Hepatitis C, Chronic; Hepatitis B, Chronic
Date of authorisation: 09/03/2000, Revision: 11, Withdrawn, Last updated: 19/11/2008 -
List item
Withdrawn application: Veraseal
date of withdrawal: 29/09/2015, Initial authorisation, Last updated: 10/12/2000September 2015, Instituto Grifols S.A. officially notified … -
List item
Referral: Factor VIII
associated names: Iblias, Elocta, Kovaltry, Nuwiq, Obizur, NovoEight, Voncento, ReFacto AF, Kogenate Bayer, Helixate NexGen, Advate, Article 31 referrals
Status: European Commission final decision, opinion/position date: 14/09/2017, EC decision date: 10/10/2017, Last updated: 05/12/2017 -
List item
Opinion on medicine for use outside EU: Fexinidazole Winthrop
fexinidazole, Trypanosomiasis, African, ATC code: P01CA03 Opinion number: H-W-2320, Positive opinion Opinion date: 15/11/2018, Last updated: 22/12/2022 -
List item
Orphan designation: Fibrinogen-coated albumin spheres for: Treatment of Ebola virus disease
Date of designation: 12/02/2015, Positive, Last updated: 22/05/2019Fibrinogenom obložene sfere albumina Liječenje Ebola virusne … kezelése Italian Sfere di albumina rivestite di fibrinogeno … -
List item
Orphan designation: Fibrinogen-coated albumin spheres for: Treatment of acute radiation syndrome
Date of designation: 10/08/2015, Positive, Last updated: 22/05/2019kezelése Italian Sfere di albumina rivestite di fibrinogeno … -
List item
Orphan designation: Recombinant fusion protein linking coagulation factor VIIa with albumin for: Treatment of congenital factor VII deficiency
Date of designation: 07/10/2013, Positive, Last updated: 28/03/2018 -
List item
Orphan designation: Recombinant fusion protein linking human coagulation factor VIIa with human albumin for: Treatment of haemophilia A
Date of designation: 15/04/2011, Positive, Last updated: 28/03/2018coagulazione del sangue umano ed albumina umana Trattamento dell’emofilia … -
List item
Orphan designation: Recombinant fusion protein linking human coagulation factor VIIa with human albumin for: Treatment of haemophilia B
Date of designation: 13/05/2011, Positive, Last updated: 28/03/2018coagulazione del sangue umano ed albumina umana Trattamento dell’emofilia … -
List item
Orphan designation: Recombinant fusion protein linking human coagulation factor IX with human albumin for: Treatment of haemophilia B
Date of designation: 04/02/2010, Positive, Last updated: 28/03/2018 -
List item
Orphan designation: Nanoparticle albumin-bound paclitaxel for: Treatment of pancreatic cancer
Date of designation: 26/11/2010, Withdrawn, Last updated: 11/03/2013